By

Melanie Murray
Myeloma New Zealand has started a campaign to press Pharmac into funding a treatment that has been standard-of-care throughout the Organisation for Economic Co-operation and Development (OECD) for more than five years. Myeloma NZ trustee Nichola Oakenfull has been interviewed for the article, well done Nichola! Here is the RNZ article: https://www.rnz.co.nz/news/national/474629/blood-cancer-patient-charity-campaigns-for-pharmac-to-fund-medicine
Continue Reading
MEDIA RELEASE 7 September 2022 New Zealanders living with multiple myeloma, a deadly, relapsing/remitting blood cancer, are mounting a major, evidence-based campaign to press Pharmac into funding a transformative treatment that has been standard-of-care throughout the OECD for more than 5 years.    Myeloma patient and trustee of Myeloma NZ Nichola Oakenfull says patients who’ve...
Continue Reading
I hope that you are all keeping as well as possible with all these viruses circulating at the moment. I see from some comments on the Facebook page that some of you have used Paxlovid at the onset of Covid symptoms and found this intervention helpful. It is a challenging time for myeloma patients and...
Continue Reading
OPINION: How long does it take you to make a decision about whether or not to buy something? You’ve got all the information in front of you. You know it’s a good product. It works. You need it. And you’ve got the money to buy it. So how long will it take? What if I said...
Continue Reading
In August 2022, Myeloma New Zealand is hosting its 4th Myeloma Summit for medical professionals in Queenstown. Held in 2016,2018, 2020 and now again in 2022, the Summit brings together medical professionals involved with Myeloma in NZ to share and to learn from one another and from the international speakers who join the meeting.  This year...
Continue Reading
MEDIA RELEASE DOCTOR CALLS ON MINISTER LITTLE TO RELEASE ‘BURIED’ INDEPENDENT REPORT ON PHARMAC The final report of the Independent Pharmac Review Panel has been sitting with Health Minister Andrew Little since February, with no reason offered for why it has not been released, says Myeloma NZ Chief Executive Dr Ken Romeril. “Given the damning...
Continue Reading
Congratulations on your very well-deserved appointment to The New Zealand Order of Merit for your services to Haematology! Dr Ken Romeril is a consultant physician/haematologist. Dr Ken Romeril (Ken) founded the charitable trust Myeloma New Zealand, of which he has been CEO since 2016, continuing in this role following retirement from clinical practice. He is the...
Continue Reading
1 2 3 25

Floor 7, 90 The Terrace
Wellington Central
New Zealand